PDL BioPharma News

In the May issue of Portfolio Manager's Review - " The Superinvestor Issue ," our team highlighted 100 companies owned by well respected investors and profiled 30 of them.

A dissident shareholder of Facet Biotech Corp. - the spinout of PDL BioPharma - withdrew his slate of directors for election at the company's annual meeting.

Biotech company AnaSpec Inc. said this week it is moving from San Jose to Fremont.

INCLINE VILLAGE, Nev. A company that describes itself as a pioneer in the creation of monoclonal antibodies for use in humans has appointed a new vice president.

We are adding Facet Biotech Corporation to our ValueHuntr Portfolio . FACT is a company with a market cap of $239M with $295M of net-cash as of December 31, 2008.

Sun Pharmaceutical Industries has lost a patent infringement case in the US on Cardene, a drug for controlling high blood pressure.

PDL BioPharma was a biotech research and development company until recently when it spun-off the research and development portion of the business, leaving behind six employees and seven patents to protect.

INCLINE VILLAGE, NV, March 26 / MARKET WIRE/ -- PDL BioPharma, Inc. today announced revenue guidance for the first quarter ended March 31, 2009 of approximately $60 million, as compared with $50 million for the first quarter of 2008.

PDL BioPharma, Inc. today announced an adjustment to the conversion rate for its 2.75% Convertible Subordinated Notes due August 16, 2023 .

When fund manager Joel Greenblatt published his investing tome, The Little Book That Beats the Market , in 2005, it marked a unique point for investors.

BUYINS.NET, www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for March 9, 2009.

OTC Select tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts by visiting OTC Select at the following: http://www.otcselect.com. Today's early morning Nasdaq ...

PDL BioPharma, Inc. March 2, 2009 4:30 pm ET Executives David Carey a ' IR, Lazar Partners Ltd.

Shares of PDL Biopharma Inc. jumped Tuesday after the drug developer reported fourth-quarter results above analyst estimates.

Prior to joning PDL, Stone served as VP of legal affairs and corporate secretary at LS9, an advanced biofuels development company.

PDL BioPharma, Inc. and Alexion Pharmaceuticals, Inc. today jointly announced that the companies have entered into a definitive license agreement and settlement agreement that resolve the legal disputes between ...

PDL BioPharma Inc. and Alexion Pharmaceuticals Inc. said Monday they settled a patent dispute over the blood disorder drug Soliris, in a cash for rights exchange.

Alexion Pharmaceuticals Inc. to Pay $25 Million to PDL BioPharma, Inc. in Patent Dispute INCLINE VILLAGE, Nev., and CHESHIRE, Conn., Jan.

PDL BioPharma Inc. has spun off its biotech business into Facet Biotech Corp. and moved its headquarters to Incline Village, Nevada.

Shares of PDL BioPharma Inc. plunged Friday, ahead of the biotechnology company's removal from the S&P MidCap 400 index as it spins off its biotech operations.